We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Ernest Kawka Ernest Kawka is PhRMA’s deputy vice president for international intellectual property. Previously, he worked for industry’s international trade association in Geneva, Switzerland focusing on intellectual property and trade policies. He received a law degree from University of New Hampshire School of Law.
More than two years into the COVID-19 pandemic, the world has witnessed the immense value of biopharmaceutical innovation. With numerous safe and effective vaccines and treatments developed in record...
PhRMA’s recently submitted comments to the Office of the U.S. Trade Representative (USTR)’s 2022 Special 301 Report reinforce how the United States can confirm its strong commitment to defend...
Over the last year, the world has witnessed the importance of strong innovation policies as intellectual property protection and market access policies facilitated the research, development and...
Pharmaceutical Research and Manufacturers of America® 950 F Street, NW Suite 300, Washington, DC 20004